ArticleJournal of chemical information and modeling2026
Integrating Multiview Information for Enhanced Deep Learning-Based Acute Dermal Toxicity Prediction.
Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate prediction of acute dermal toxicity is vital for the safe and effective development of contact drugs. While numerous deep learning models have been created to replace costly and ethically challenging animal toxicity tests, most approaches overlook the multiview information on molecules. To overcome this limitation, we introduce a novel model named MVIToxNet, which integrates multiview features from both molecular fingerprints and SMILES sequences. To capture the multiview information on SMILES, MVIToxNet incorporates character-level and atom-level features. In addition, byte-pair encoding tokenization is utilized to capture substructural details within molecules, allowing the model to differentiate similar SMILES by assigning distinct tokens to different substructures. Since the data sets in this study are small and imbalanced, we argue that selecting a single model based solely on the best validation performance may not reliably reflect the best generalization for test sets. Therefore, we propose a weighted model averaging approach that combines multiple trained models according to their top-K validation scores into one model, yielding an improved model for inference. Extensive experimental results demonstrate that MVIToxNet significantly outperforms existing baselines in acute dermal toxicity prediction, validating the effectiveness of utilizing multiview features and the weighted model averaging strategy. Furthermore, our proposed methods demonstrate the potential for data-driven model design.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.